GlaxoSmithKline reported 1.08B in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US $ 3295M 1422M
Alcon AG ALC:SW 246M 64M
Amgen AMGN:US $ 2176M 324M
Artemis Alpha ATS:LN -10207000 58.81M
AstraZeneca AZN:LN 539M 339M
Bayer BAYN:GR 4.21B 2.19B
Biogen BIIB:US $ -59.1M 669.8M
Bristol Myers Squibb BMY:US $ 2590M 37M
Eli Lilly And LLY:US $ 1210.1M 1194.2M
Fresenius FRE:GR € 902M 221M
Fresenius Medical Care FME:GR € 341M 6.67M
Galapagos GLPG:NA -76332000 55.19M
Genmab GEN:DC 514M 295M
Gilead Sciences GILD:US $ 2029M 1832M
GlaxoSmithKline GSK:LN 1.08B 1.72B
Glaxosmithkline GSK:US $ 1081M 1720M
Hikma Pharmaceutical HIK:LN 249M 6M
Lonza Group LONN:SW 645M 111M
Merk MRK:US $ 4927M 642M
Novartis NOVN:VX 2.23B 624M
Orion ORNBV:FH 82M 10.5M
Pfizer PFE:US $ 12102M 2229M
Philips PHIA:NA € 11M 192M
Recordati REC:IM 99.13M 32.14M
Regeneron Pharmaceuticals REGN:US $ 1109.9M 148.6M